Application Nr Approved Date Route Status External Links
BLA021106 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Somavert Is Indicated For The Treatment Of Acromegaly In Patients Who Have Had An Inadequate Response To Surgery Or Radiation Therapy, Or For Whom These Therapies Are Not Appropriate. The Goal Of Treatment Is To Normalize Serum Insulin-Like Growth Factor-I (Igf-I) Levels. Somavert Is A Growth Hormone Receptor Antagonist Indicated For The Treatment Of Acromegaly In Patients Who Have Had An Inadequate Response To Surgery Or Radiation Therapy, Or For Whom These Therapies Are Not Appropriate. The Goal Of Treatment Is To Normalize Serum Insulin-Like Growth Factor-I (Igf-I) Levels. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pegvisomant

Comments